Interestingly, pathway analysis revealed that the identified DSGs in 22Rv1 with METTL3 inhibition were significantly enriched in pathways such as Fanconi anemia pathway, metabolic pathways, base excision repair, aminoacyl-tRNA biosynthesis, and RNA degradation (Figure 3D and Table S6). The gene discussed is METTL3; the disease is Fanconi anemia.